Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Mounjaro is the first and only approved once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist
Who Should NOT Take GLP-1 Drugs: Gallbladder Problems People with active gallbladder disease should use GLP-1 drugs with caution
Semaglutide can cause a number of other side effects
Patients with severe renal impairment or end-stage renal disease requiring dialysis may need special consideration when using Semaglutide / Cyanocobalamin Injection
Most patients report that headaches diminish as their body adjusts to the medication over 24 weeks
US$ 26.21
US$ 22.12
US$ 28.57
US$ 26.82
US$ 26.51
US$ 21.56
